SCHEMBL1961881

SCHEMBL1961881

O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(N2CCC(N3CCCC3)CC2)cc(C(F)(F)F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CSF1R P07333 5/20 0.47
P2RX1 P51575 3/20 0.46
TRPV4 Q9HBA0 1/20 0.46
NPY2R P49146 1/20 0.46
L3MBTL3 Q96JM7 2/20 0.44
L3MBTL1 Q9Y468 2/20 0.44
RAF1 P04049 1/20 0.43
LYN P07948 1/20 0.43
BRAF P15056 1/20 0.43
MCHR1 Q99705 1/20 0.43
HDAC3 O15379 1/20 0.43
HDAC8 Q9BY41 1/20 0.43
HDAC6 Q9UBN7 1/20 0.43
DDR1 Q08345 1/20 0.42
MBTD1 Q05BQ5 1/20 0.42
TP53BP1 Q12888 1/20 0.42
L3MBTL4 Q8NA19 1/20 0.42
JUN P05412 1/20 0.42
NFKB1 P19838 1/20 0.42
NFKB2 Q00653 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1420252 0.98 CSF1R (0.47) CSF1RP2RX1TRPV4NPY2RL3MBTL3
SCHEMBL1420952 0.95 NPY2R (0.47) CSF1RP2RX1TRPV4NPY2RL3MBTL3
SCHEMBL1420090 0.94 CSF1R (0.45) CSF1RP2RX1TRPV4NPY2RL3MBTL3
SCHEMBL1420444 0.92 CSF1R (0.47) CSF1RTRPV4NPY2RL3MBTL3L3MBTL1
SCHEMBL1420533 0.91 TRPV4 (0.57) CSF1RTRPV4NPY2RL3MBTL3L3MBTL1
SCHEMBL1420819 0.91 NPY2R (0.53) CSF1RP2RX1TRPV4NPY2RL3MBTL3
SCHEMBL1420117 0.90 LMNA (0.49) CSF1RP2RX1TRPV4NPY2RL3MBTL3
SCHEMBL1420504 0.90 TMPRSS4 (0.46) CSF1RP2RX1RAF1BRAFDDR1
SCHEMBL1420450 0.90 NPY2R (0.54) CSF1RP2RX1TRPV4NPY2RRAF1
SCHEMBL1420274 0.89 P2RX1 (0.59) CSF1RP2RX1NPY2RL3MBTL3L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110144107-A1 COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF MALARIA IRM LLC (BM) 2011-06-16 US claimed
US-20110144107-A1 COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF MALARIA IRM LLC (BM) 2011-06-16 US disclosed
US-20110144107-A1 COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF MALARIA IRM LLC (BM) 2011-06-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110144107-A1 COMPOUNDS AND COMPOSITIONS USEFUL FOR THE TREATMENT OF MALARIA G6PD, DHFR, SGMS1 CSF1R 2076/4885P2RX1 3974/4885TRPV4 3736/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.